The immediate effects of chlorpromazine in newly admitted schizophrenic patients - PubMed (original) (raw)

Clinical Trial

The immediate effects of chlorpromazine in newly admitted schizophrenic patients

W T Hamill et al. Am J Psychiatry. 1975 Oct.

Abstract

To evaluate the clinical effectiveness of chlorpromazine in comparison with placebo over a brief period of hospitalization, the authors conducted a double-blind study of the drug in 44 acutely ill schizophrenic patients. These patients had been newly admitted to a brief treatment unit where the average length of stay was 7 to 10 days. The results of this study indicate that chlorpromazine had no more calming or antipsychotic effect than placebo during the first 5 days of treatment. The authors suggest that 5 days is too short a time for a clinical trial to gauge patient response to chlorpromazine.

PubMed Disclaimer

Similar articles

• Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
  Shopsin B, Klein H, Aaronsom M, Collora M. Shopsin B, et al. Arch Gen Psychiatry. 1979 Jun;36(6):657-64. doi: 10.1001/archpsyc.1979.01780060047005. Arch Gen Psychiatry. 1979. PMID: 375865 Clinical Trial.
• Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
  Rickels K, Byrdy H, Valentine J, Postel W, Norstad N, Downing R. Rickels K, et al. Int Pharmacopsychiatry. 1978;13(1):50-7. doi: 10.1159/000468321. Int Pharmacopsychiatry. 1978. PMID: 342437 Clinical Trial.
• Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation.
  Hamid TA, Wertz WJ. Hamid TA, et al. Am J Psychiatry. 1973 Jun;130(6):689-92. doi: 10.1176/ajp.130.6.689. Am J Psychiatry. 1973. PMID: 4573820 Clinical Trial. No abstract available.
• Maintenance therapy and schizophrenia.
  Leff JP. Leff JP. Br J Psychiatry. 1975;Spec No 9:55-8. Br J Psychiatry. 1975. PMID: 241453 Review. No abstract available.
• The direct effects of compliance on health outcome.
  Epstein LH. Epstein LH. Health Psychol. 1984;3(4):385-93. doi: 10.1037//0278-6133.3.4.385. Health Psychol. 1984. PMID: 6399250 Review.

Cited by

• Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials.
  Adams CE, Rathbone J, Thornley B, Clarke M, Borrill J, Wahlbeck K, Awad AG. Adams CE, et al. BMC Med. 2005 Oct 17;3:15. doi: 10.1186/1741-7015-3-15. BMC Med. 2005. PMID: 16229742 Free PMC article. Review.
• Chlorpromazine versus placebo for schizophrenia.
  Adams CE, Awad GA, Rathbone J, Thornley B, Soares-Weiser K. Adams CE, et al. Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3. Cochrane Database Syst Rev. 2014. PMID: 24395698 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon